dasatinib synthon 100mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 100 mg - antineoplastic agents
dasatinib synthon 140mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - dasatinib - film-coated tablet - dasatinib 140 mg - antineoplastic agents
dasatinib krka 100 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 100 milligram(s) - dasatinib
dasatinib krka 140 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 140 milligram(s) - dasatinib
dasatinib krka 20 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 20 milligram(s) - dasatinib
dasatinib krka 50 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 50 milligram(s) - dasatinib
dasatinib krka 70 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 70 milligram(s) - dasatinib
dasatinib krka 80 mg film-coated tablets
krka, d.d., novo mesto - dasatinib - film-coated tablet - 80 milligram(s) - dasatinib
dasatinib dr.reddy's dasatinib 100 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 116 mg (equivalent: dasatinib, qty 100 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; lactose; silicon dioxide; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.
dasatinib dr.reddy's dasatinib 20 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 23.2 mg (equivalent: dasatinib, qty 20 mg) - tablet, film coated - excipient ingredients: lactose; croscarmellose sodium; triacetin; hydrogenated castor oil; magnesium stearate; titanium dioxide; silicon dioxide; microcrystalline cellulose; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.